Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 301–400 of 1,000
Vargas-Caballero, M., Martin, L. J., Salter, M. W., Orser, B. A., & Paulsen, O. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.005 · Cited by 52
Gourley, S. L., DeBold, J. F., Yin, W., Cook, J. M., & Miczek, K. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1987-3 · Cited by 57
Anxiolytic-like Effects by trans-Ferulic Acid Possibly Occur through GABAergic Interaction Pathways
Bhuia, M. S., Rokonuzzman, M., Hossain, M. I., Ansari, S. A., Ansari, I. A., Islam, T., Hasan, M. S. A., Mubarak, M. S., & Islam, M. T. (2023) · Pharmaceuticals · doi:10.3390/ph16091271 · Cited by 56
Modulation of GABAA receptor gene expression by allopregnanolone and ethanol
Follesa, P., Biggio, F., Caria, S., Gorini, G., & Biggio, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.041 · Cited by 57
Stefanits, H., Milenković, I., Mahr, N., Pataraia, E., Hainfellner, J. A., Kovács, G. G., Sieghart, W., Yilmazer‐Hanke, D., & Czech, T. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24337 · Cited by 56
Anxiolytic-like action of diazepam: which GABAA receptor subtype is involved?
Reynolds, D. S., McKernan, R. M., & Dawson, G. R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01773-9 · Cited by 56
Self-citationTargeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Development and SAR of functionally selective allosteric modulators of GABAA receptors
Alhambra, C., Becker, C., Blake, T., Chang, A. (.-F., Damewood, J. R., Daniels, T. S., Dembofsky, B. T., Gurley, D. A., Hall, J. E., Herzog, K. J., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.035 · Cited by 55
Munro, G., Erichsen, H. K., Rae, M. G., & Mirza, N. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.017 · Cited by 55
Gibson, C. J., Meyer, R. C., & Hamm, R. J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-38 · Cited by 55
GABAA Receptor α Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment
Vinkers, C. H., van Oorschot, R., Nielsen, E. Ø., Cook, J. M., Hansen, H. H., Groenink, L., Olivier, B., & Mirza, N. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043054 · Cited by 47
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study
Voshaar, R. C. O., van Balkom, A. J. L. M., & Zitman, F. G. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.09.007 · Cited by 55
The fate of interneurons, GABA A receptor sub‐types and perineuronal nets in Alzheimer's disease
Ali, A. B., Islam, A., & Constanti, A. (2022) · Brain Pathology · doi:10.1111/bpa.13129 · Cited by 55
Cameron, M., Foster, B. S., Lynch, J. E., Shi, Y., & Dolling, U. (2006) · Organic Process Research & Development · doi:10.1021/op050217j · Cited by 54
Paul, J., Yévenes, G. E., Benke, D., Lio, A. D., Ralvenius, W. T., Witschi, R., Scheurer, L., Cook, J. M., Rudolph, U., Fritschy, J.-M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.221 · Cited by 47
Peña, I. J. D., Kim, H. J., de la Peña, J. B., Kim, M., Botanas, C. J., You, K. Y., Woo, T., Lee, Y. S., Jung, J., Kim, K., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.013 · Cited by 54
Anzini, M., Valenti, S., Braile, C., Cappelli, A., Vomero, S., Alcaro, S., Ortuso, F., Marinelli, L., Limongelli, V., Novellino, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001597 · Cited by 55
Wen, Y., Dong, Z., Liu, J., Axerio-Cilies, P., Du, Y., Li, J., Chen, L., Zhang, L., Liu, L., Lu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01148-y · Cited by 53
Gallos, G., Yocum, G. T., Siviski, M. E., Yim, P. D., Fu, X. W., Poe, M. M., Cook, J. M., Harrison, N. L., Perez‐Zoghbi, J. F., & Emala, C. W. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00107.2014 · Cited by 53
Fitzgerald, A. C., Wright, B. T., & Heldt, S. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3457-x · Cited by 53
Bailey, J., Papadopoulos, A., Seddon, K., & Nutt, D. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089603 · Cited by 46
Poe, M. M., Methuku, K. R., Li, G., Verma, A. R., Teske, K. A., Stafford, D. C., Arnold, L. A., Cramer, J. W., Jones, T. M., Cerne, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01332 · Cited by 53
Scott‐Stevens, P., Atack, J. R., Sohal, B., & Worboys, P. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.423 · Cited by 50
Self-citationOwen, R. M., Blakemore, D. C., Cao, L., Flanagan, N. J., Fish, R. L., Gibson, K. R., Gurrell, R., Huh, C. W., Kammonen, J., Mortimer‐Cassen, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00322 · Cited by 53
Self-citationAtack, J. R. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57004-9 · Cited by 52
Self-citationAcute exposure to waterborne psychoactive drugs attract zebrafish
de Abreu, M. S., Giacomini, A. C. V. V., Gusso, D., da Rosa, J. G. S., Koakoski, G., Kalichak, F., Idalêncio, R., Oliveira, T. A., Barcellos, H. H. A., Bonan, C. D., et al. (2015) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2015.08.009 · Cited by 52
Russell, M. G. N., Carling, R. W., Street, L. J., Hallett, D. J., Goodacre, S. C., Mezzogori, E., Reader, M., Cook, S. M., Bromidge, F. A., Newman, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051200u · Cited by 52
Self-citationGrigoriadis, D. E., Hoare, S. R. J., Lechner, S. M., Slee, D. H., & Williams, J. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.149 · Cited by 52
Werner, D. F., Blednov, Y. A., Ariwodola, O. J., Silberman, Y., Logan, E., Berry, R. B., Borghese, C. M., Matthews, D. B., Weiner, J. L., Harrison, N. L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106161 · Cited by 52
Chen, X., Jacobs, G. E., de Kam, M., Jaeger, J., Lappalainen, J., Maruff, P. T., Smith, M. A., Cross, A. J., Cohen, A. F., & van Gerven, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12413 · Cited by 54
Development of Subtype Selective GABAAModulators
Dawson, G. R., Collinson, N., & Atack, J. R. (2005) · CNS Spectrums · doi:10.1017/s1092852900009871 · Cited by 44
Self-citationLower anxiety and a decrease in agonistic behaviour in Lsamp-deficient mice
Innos, J., Philips, M., Leidmaa, E., Heinla, I., Raud, S., Reemann, P., Plaas, M., Nurk, K., Kurrikoff, K., Matto, V., et al. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.09.019 · Cited by 51
Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies
González, L. A., Gatch, M. B., Taylor, C. M., Bell-Horner, C. L., Forster, M. J., & Dillon, G. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151142 · Cited by 51
Modifying quinolone antibiotics yields new anxiolytics
Johnstone, T. B. C., Hogenkamp, D. J., Coyne, L., Su, J., Halliwell, R. F., Tran, M. B., Yoshimura, R. F., Li, W.-Y., Wang, J., & Gee, K. W. (2003) · Nature Medicine · doi:10.1038/nm967 · Cited by 51
GABAA receptor modulation: Potential to deliver novel pain medicines?
Munro, G., Hansen, R. B., & Mirza, N. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.070 · Cited by 50
Restoring the Spinal Pain Gate
Zeilhofer, H. U., Ralvenius, W. T., & Acuña, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.007 · Cited by 50
Reynolds, L. M., Engin, E., Tantillo, G., Lau, H. M., Muschamp, J. W., Carlezon, W. A., & Rudolph, U. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.115 · Cited by 49
Milić, M., Divljaković, J., Rallapalli, S., Linn, M. L. V., Stamenić, T. T., Cook, J. M., & Savić, M. M. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283512c85 · Cited by 50
Neuronal Glutamate and GABAA Receptor Function in Health and Disease
Moult, P. R. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371317 · Cited by 49
Fatemi, S. H., Folsom, T. D., & THURAS, P. D. (2017) · Synapse · doi:10.1002/syn.21973 · Cited by 49
Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection
Sanders, R., Grover, V., Goulding, J., Godlee, A., Gurney, S., Snelgrove, R. J., Ma, D., Singh, S., Maze, M., & Hussell, T. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.001 · Cited by 49
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., Cook, J. M., Yin, W., & Bokonjić, D. R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.07.013 · Cited by 49
Epilepsy: key experimental therapeutics in early clinical development
Steriade, C., French, J. A., & Devinsky, O. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1743678 · Cited by 48
Rodríguez‐Landa, J. F., Guillén-Ruiz, G., Hernández-López, F., Cueto‐Escobedo, J., Rivadeneyra-Domínguez, E., Bernal‐Morales, B., & Herrera-Huerta, E. V. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112952 · Cited by 48
Zuo, W., Zhao, J., Zhang, J., Fang, Z., Deng, J., Fan, Z., Guo, Y., Han, J., Hou, W., Dong, H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02246-4 · Cited by 48
Sites of action of sleep and wake drugs: insights from model organisms
Rihel, J., & Schier, A. F. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.04.010 · Cited by 48
Fernández, S. P., Mewett, K. N., Hanrahan, J. R., Chebib, M., & Johnston, G. A. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.069 · Cited by 48
Anxiolytics targeting GABA A receptors: Insights on etifoxine
Poisbeau, P., Gazzo, G., & Calvel, L. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468030 · Cited by 47
Milić, M., Stamenić, T. T., Joksimovic, S. M., Biawat, P., Rallapalli, S., Divljaković, J., Radulović, T., Cook, J. M., & Savić, M. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.016 · Cited by 47
Richter, G., Liao, V. W. Y., Ahring, P. K., & Chebib, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.599812 · Cited by 48
Smith, A. J., Oxley, B., Malpas, S., Pillai, G. V., & Simpson, P. B. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070342 · Cited by 47
GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone
Biggio, G., Follesa, P., Sanna, E., Purdy, R. H., & Concas, A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46064-8 · Cited by 47
de Almeida, R. M. M., Rowlett, J. K., Cook, J. M., Yin, W., & Miczek, K. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1661-1 · Cited by 46
Mechanism of action of general anaesthetics — new information from molecular pharmacology
Thompson, S., & Wafford, K. A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00013-3 · Cited by 46
Self-citationAlcohol Actions on GABAA Receptors: From Protein Structure to Mouse Behavior
Ueno, S., Harris, R. A., Messing, R. O., Sánchez‐Pérez, A. M., Hodge, C. W., McMahon, T., Wang, D., Mehmert, K. K., Kelley, S., Haywood, A., et al. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02378.x · Cited by 46
Neurosteroid modulation of recombinant and synaptic GABAA receptors
Lambert, J. J., Harney, S. C., Belelli, D., & Peters, J. A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46063-6 · Cited by 46
Limiting Activity at β1-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia
Gee, K. W., Tran, M. B., Hogenkamp, D. J., Johnstone, T. B. C., Bagnera, R. E., Yoshimura, R. F., Huang, J.-C., Belluzzi, J. D., & Whittemore, E. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161885 · Cited by 45
Molecular Pathways of Anxiety Revealed by Knockout Mice
Tóth, M., & Wood, S. J. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:101 · Cited by 45
Voss, J., Sánchez, C., Michelsen, S., & Ebert, B. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.007 · Cited by 44
Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder
Lin, S.-K., Chen, C.-K., Ball, D., Liu, H.-C., & Loh, E.-W. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500203 · Cited by 44
Bailey, S., & Tóth, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-04.2004 · Cited by 44
Möhler, H., Rudolph, U., Boison, D., Singer, P., Feldon, J., & Yee, B. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.003 · Cited by 44
Popik, P., Kostakis, E., Krawczyk, M., Nowak, G., Szewczyk, B., Krieter, P. A., Chen, Z., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107201 · Cited by 44
Pathophysiology and Pharmacology of GABAA Receptors
Möhler, H., Fritschy, J., Vogt, K. E., Crestani, F., & Rudolph, U. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_9 · Cited by 44
The Legacy of the Benzodiazepine Receptor
Möhler, H. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.008 · Cited by 43
New Drugs for Pediatric Epilepsy
Chu, C. J., & Thiele, E. A. (2010) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2010.10.003 · Cited by 43
A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam
Tolbert, D. S., & Larsen, F. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1313 · Cited by 43
Oh, D.-R., Kim, Y., Jo, A., Choi, E. J., Oh, K.-N., Kim, J., Kang, H., Kim, Y. R., & Choi, C. Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.003 · Cited by 43
Schneider Gasser, E. M., Duveau, V., Prenosil, G. A., & Fritschy, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05558.x · Cited by 40
Olsen, R. W. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1382-3 · Cited by 43
Karim, N., Gavande, N. S., Wellendorph, P., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.002 · Cited by 43
Yin, W., Majumder, S., Clayton, T., Petrou, S., VanLinn, M. L., Namjoshi, O. A., Ma, C., Cromer, B. A., Roth, B. L., Platt, D. M., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.049 · Cited by 43
Vinkers, C. H., Mirza, N. R., Olivier, B., & Kahn, R. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.513382 · Cited by 39
Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice
Jie-shu, Y., Peng, M., Shi, J., Zheng, H.-Z., Liu, Y., Zhao, B., & Guo, J. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-223 · Cited by 43
Imidazo[1,2-a]pyrimidines as functionally selective GABAA ligands
Blackaby, W., Atack, J. R., Bromidge, F. A., Castro, J. L., Goodacre, S. C., Hallett, D. J., Lewis, R. T., Marshall, G. R., Pike, A. J., Smith, A. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.112 · Cited by 43
Self-citationLicata, S. C., Platt, D. M., Cook, J. M., Sarma, P., Griebel, G., & Rowlett, J. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081612 · Cited by 43
Heldt, S. A., & Ressler, K. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0693-10.2010 · Cited by 42
“However, unlike 1-selective agonists, both L-838,417 and SL651498 produce little or no sedation at doses which produce anxiolytic-like activity (McKernan et al., 2000; Griebel et al., 2003).”
BackgroundResultInfluentialStamenić, T. T., Poe, M. M., Rehman, S., Santrač, A., Divović, B., Scholze, P., Ernst, M. C., Cook, J. M., & Savić, M. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.016 · Cited by 42
Ravenelle, R., Neugebauer, N. M., Niedzielak, T. R., & Donaldson, S. T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.048 · Cited by 42
Understanding the Molecular Diversity of GABAergic Synapses
Sassoè-Pognetto, M., Frola, E., Pregno, G., Briatore, F., & Patrizi, A. (2011) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2011.00004 · Cited by 38
Reynolds, D. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.015 · Cited by 42
Self-citationMolecular mechanisms of tolerance to and withdrawal of GABAA receptor modulators
Biggio, G., Dazzi, L., Biggio, F., Mancuso, L., Talani, G., Busonero, F., Mostallino, M. C., Sanna, E., & Follesa, P. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.002 · Cited by 43
Ramirez, A. D., Gotter, A. L., Fox, S. V., Tannenbaum, P. L., Yao, L., Tye, S. J., McDonald, T. P., Brunner, J., Garson, S. L., Reiss, D. R., et al. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00254 · Cited by 41
Wheless, J. W., & Phelps, S. J. (2012) · Journal of Child Neurology · doi:10.1177/0883073812463609 · Cited by 41
Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei
Kang-Park, M.-H., Wilson, W. A., & Moore, S. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00340-x · Cited by 41
Rowlett, J. K., Lelas, S., Tornatzky, W., & Licata, S. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0228-8 · Cited by 41
Engin, E., Bakhurin, K. I., Smith, K. S., Hines, R. M., Reynolds, L. M., Tang, W., Sprengel, R., Moss, S. J., & Rudolph, U. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.41 · Cited by 40
Photosensitive epilepsy: Robust clinical efficacy of a selective GABA potentiator
Gurrell, R., Gorman, D. N., Whitlock, M., Ogden, A. G., Reynolds, D. S., DiVentura, B. D., Abou-Khalil, B. W., Gelfand, M. A., Pollard, J., Hogan, R. E., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007271 · Cited by 40
Self-citationDiazepam leads to enhanced severity of orthopoxvirus infection and immune suppression
Huemer, H. P., Lassnig, C., Nowotny, N. R., Irschick, E. U., Kitchen, M., & Pavlic, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.032 · Cited by 40
Mathiasen, L., Mirza, N. R., & Rodgers, R. J. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.014 · Cited by 40
Cortical Glutamatergic Neurons Mediate the Motor Sedative Action of Diazepam
Zeller, A., Crestani, F., Camenisch, I., Iwasato, T., Itohara, S., Fritschy, J., & Rudolph, U. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038828 · Cited by 40
Werner, D. F., Swihart, A., Rau, V., Jia, F., Borghese, C. M., McCracken, M. L., Iyer, S. V., Fanselow, M. S., Oh, I., Sonner, J. M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170431 · Cited by 40
Rowlett, J. K., Cook, J. M., Duke, A. N., & Platt, D. M. (2005) · CNS Spectrums · doi:10.1017/s1092852900009895 · Cited by 40
Platt, D. M., Rowlett, J. K., Spealman, R. D., Cook, J. M., & Ma, C. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1189-9 · Cited by 40
Humulone Modulation of GABAA Receptors and Its Role in Hops Sleep-Promoting Activity
Benkherouf, A. Y., Eerola, K., Soini, S. L., & Uusi‐Oukari, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.594708 · Cited by 40
Licata, S. C., Jensen, J. E., Penetar, D. M., Prescot, A. P., Lukas, S. E., & Renshaw, P. F. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1431-1 · Cited by 39
GABA pharmacology—what prospects for the future?
Iversen, L. L. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.039 · Cited by 39
Differential expression of GABAA receptor subunits in the distinct nuclei of the rat amygdala
Fujimura, J., Nagano, M., & Suzuki, H. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.03.013 · Cited by 40
Burt, D. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00505-8 · Cited by 39
Mirza, N. R., & Nielsen, E. Ø. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094474 · Cited by 38
“Recently, two ligands, L-838,417 (McKernan et al., 2000) and SL651498 (Griebel et al., 2001), have been described that show selectivity for non- 1-containing GABAA receptors, i.e., a profile that is in many ways opposite to that of the GABAA1-selective drug zolpidem (see below).”
BackgroundResultInfluential
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.